NAVEEN PEMMARAJU to Clinical Trials, Phase II as Topic
This is a "connection" page, showing publications NAVEEN PEMMARAJU has written about Clinical Trials, Phase II as Topic.
Connection Strength
0.236
-
Evaluating tagraxofusp for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN). Expert Opin Pharmacother. 2022 Mar; 23(4):431-438.
Score: 0.166
-
Venetoclax with decitabine vs intensive chemotherapy in acute myeloid leukemia: A propensity score matched analysis stratified by risk of treatment-related mortality. Am J Hematol. 2021 03 01; 96(3):282-291.
Score: 0.038
-
Clearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid Leukemia. J Clin Oncol. 2018 06 20; 36(18):1788-1797.
Score: 0.032